Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Clinically amyopathic dermatomyositis (CADM) is associated with antibodies directed against the protein encoded by the melanoma differentiation-associated gene 5 (MDA5). CADM patients have an increased risk of developing rapidly progressive interstitial lung disease (RP-ILD) and spontaneous pneumomediastinum. Two Peruvian cases of RP-ILD-associated CADM with spontaneous pneumomediastinum are presented, one of them was anti-MDA5 antibody positive. To our knowledge, this is the first report of anti-MDA5-associated CADM in the Peruvian population.

Cite

CITATION STYLE

APA

Cerna-López, J. A., Tejada-Llacsa, P. J., Valle-Farfán, F. A. de J., Alarcón, G. S., Ugarte-Gil, M. F., & Pimentel-Quiroz, V. R. (2023). Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review. Revista Colombiana de Reumatologia, 30(3), 277–282. https://doi.org/10.1016/j.rcreu.2021.06.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free